News & Perspective

Apr 23, 2015

Apr 23, 2015

Flu Scan for Apr 23, 2015

Avian flu in Niger, Taiwan, South Africa
Cloth face masks
Gene tied to severe 2009 H1N1

Feb 13, 2014

Feb 13, 2014

Flu Scan for Feb 13, 2014

H10N8 death in China
H5N1 in Cambodia, Vietnam
H7N3 vaccine trial
Rapid flu tests
Self-vaccination with patches

Feb 05, 2010

Feb 05, 2010

Global Tamiflu-resistant H1N1 cases reach 225

(CIDRAP News) – The World Health Organization (WHO) reported today that 225 cases of H1N1 flu with resistance to oseltamivir (Tamiflu) have been found worldwide, and resistant viruses have spread from person to person in several clusters but have not spilled into the community.

May 19, 2009

May 19, 2009

WHO group envisions greater production of H1N1 vaccine

(CIDRAP News) – A new report from a World Health Organization (WHO) advisory group predicts that global production of vaccine for the novel H1N1 influenza virus could be as much as 4.9 billon doses a year, far higher than previous estimates.

May 12, 2009

May 12, 2009

WHO likely to counsel restraint on antivirals for H1N1

(CIDRAP News) – The World Health Organization (WHO) plans to release clinical guidance that will say most patients sick with the novel H1N1 influenza (swine flu) will not need antiviral treatment, but the drugs should be considered for high-risk groups, a WHO official said today.

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»